Pippen Health of California, P.C., A California Professional Corporati

Internal Medicine in San Francisco, California — the CMS registry also lists obesity medicine among its taxonomies.

Practice Details

Address
333 Bush St FL 4
San Francisco, CA 94104
Geocoded location: 37.7908, -122.4031
Taxonomy
Internal Medicine
NPPES Enumeration
Listed with NPPES since 2023
Registered Contact
DIANNA BUDGEON, EVP OPERATIONS
NPPES Record Updated
July 2024

Specialty taxonomies on file (3)

  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
  • Obesity Medicine
    Preventive Medicine, Obesity Medicine
  • Internal Medicine
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Practice

Pippen Health of California, P.C., A California Professional Corporati is enumerated with NPPES as an Internal Medicine clinic; the CMS registry also lists obesity medicine among its taxonomies. The registry does not break out which specialties are staffed at this location — call ahead to confirm obesity-medicine or GLP-1 services are actively offered here.

Locally, this is 1 of 1965 Internal Medicine practices in San Francisco carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • •A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • •Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • •A discussion of GLP-1 options for diabetes and/or weight management.
  • •A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Pippen Health of California, P.C., A California Professional Corporati's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 425-306-0834.

GLP-1 access in San Francisco, California

Adult obesity rate
28.1%
#44 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$219/mo
Typical California telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
California Medicaid, obesity indication

About 28.1% of California adults have obesity (BMI 30+), ranking the state #44 of 50 (CDC BRFSS). Our directory currently lists 144 GLP-1-relevant clinics in San Francisco. If a cash-pay route makes more sense, compounded semaglutide through California telehealth averages about $219/mo — well below brand-name Wegovy or Zepbound.

Explore more California options on the best California GLP-1 providers page, browse every San Francisco listing in the San Francisco clinic directory.

Related Practices in San Francisco

Other San Francisco listings in the same directory tier:

PAC Lap Inc
Physician Assistant, Surgical
Psinc Inc
Bariatric Surgery
Mochi Medical, P.A.
Bariatric Surgery

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to California addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured California telehealth partners:

Featured Partners · San Francisco

Featured GLP-1 providers serving San Francisco

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  2. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  3. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  4. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
  5. 7.9
    Trimi Health

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  6. 8.1
    bmiMD

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
See all 171 GLP-1 providers serving San Francisco ↓

See more San Francisco options on the San Francisco clinic directory, our San Francisco GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by San Francisco obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Pippen Health of California, P.C., A California Professional Corporati's specialty taxonomy but not the specific medications it prescribes or its current service menu. Pippen Health of California, P.C., A California Professional Corporati is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 425-306-0834 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Pippen Health of California, P.C., A California Professional Corporati's primary specialty on file is Internal Medicine, and the registry also lists obesity medicine among its taxonomies. The registry records the taxonomy on file, not the individual clinicians staffed at this location.
Pippen Health of California, P.C., A California Professional Corporati is located at 333 Bush St FL 4, San Francisco, CA 94104. The phone number listed in the registry is 425-306-0834. Its full record is public in the CMS National Provider registry under NPI 1013792514.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Pippen Health of California, P.C., A California Professional Corporati is currently accepting new patients. Call the practice at 425-306-0834 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.